Sarah Geers represents pharmaceutical clients in intellectual property litigation in a variety of venues, including in district court, arbitration, and at the PTAB. Her practice spans Hatch-Waxman and other patent infringement actions, inter partes review proceedings, trade secret and misappropriation actions, and patent prosecution strategy advice. In addition to intellectual property matters, she has litigated a variety of commercial disputes, including antitrust, securities, and fraud claims. Her litigation experience spans discovery, trial, and appeal.
Sarah was involved in the successful resolution of Hatch-Waxman litigation involving the transdermal patch Butrans® and continues to be involved in a plethora of patent infringement actions involving the pain medication OxyContin®.
Sarah recently successfully represented a pro bono client in obtaining permanent resident status pursuant to a VAWA battered spouse waiver, in conjunction with the Her Justice program.
Before becoming an attorney, Sarah worked as a research chemist at Merck & Co., where she was responsible for solid dosage form development and associated preformulation research. While at Merck, she also participated as a patent department intern in patent prosecution and counseling. In addition, Sarah previously served for one year as a pro bono staff attorney at the New Jersey Institute for Social Justice in Newark, New Jersey.
- Seton Hall University (J.D. summa cum laude 2010; Order of the Coif; Comments Editor, Law Review); University of Minnesota (B.S. in Chemistry with high distinction and B.A. in Spanish Studies with high distinction 2003; Tau Beta Pi)
- New York, New Jersey, and registered to practice before the U.S. Patent and Trademark Office
- Conversational Spanish